Abstract
Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that have been implicated in a variety of biologic processes. The PPARdelta isotype was recently proposed as a downstream target of the adenomatous polyposis coli (APC)/beta-catenin pathway in colorectal carcinogenesis. To evaluate its role in tumorigenesis, a PPARdelta null cell line was created by targeted homologous recombination. When inoculated as xenografts in nude mice, PPARdelta -/- cells exhibited a decreased ability to form tumors compared with PPARdelta +/- and wild-type controls. These data suggest that suppression of PPARdelta expression contributes to the growth-inhibitory effects of the APC tumor suppressor.
MeSH Terms
Anti-Inflammatory Agents, Non-Steroidal/pharmacology
Apoptosis/drug effects
Base Sequence
Cell Transformation, Neoplastic/genetics
Colorectal Neoplasms/genetics,pathology
DNA Primers
Humans
Receptors, Cytoplasmic and Nuclear/genetics,physiology
Sulindac/pharmacology
Transcription Factors/genetics,physiology
Tumor Cells, Cultured
Chemicals
Anti-Inflammatory Agents, Non-Steroidal
DNA Primers
Receptors, Cytoplasmic and Nuclear
Transcription Factors
Sulindac
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Park B H
Johns Hopkins Oncology Center and Howard Hughes Medical Institute, 1650 Orleans Street, Room 590, Baltimore, MD 21231, USA.
Vogelstein B
Kinzler K W
References (27)
27 references, click to expand
-
Peroxisome proliferator-activated receptors: insight into multiple cellular functions.
Mutat Res. 2000 Mar 17;448(2):121-38
PMID: 10725467
-
PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs.
Cell. 1999 Oct 29;99(3):335-45
PMID: 10555149
-
Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta).
Mol Cell Biol. 2000 Jul;20(14):5119-28
PMID: 10866668
-
Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer.
Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13275-80
PMID: 11087869
-
Surfing the p53 network.
Nature. 2000 Nov 16;408(6810):307-10
PMID: 11099028
-
Frequent activation of the beta-catenin-Tcf signaling pathway in nonfamilial colorectal carcinomas with microsatellite instability.
Genes Chromosomes Cancer. 2001 Jan;30(1):32-7
PMID: 11107173
-
Altered growth of human colon cancer cell lines disrupted at activated Ki-ras.
Science. 1993 Apr 2;260(5104):85-8
PMID: 8465203
-
Manipulation of transgenes by site-specific recombination: use of Cre recombinase.
Methods Enzymol. 1993;225:890-900
PMID: 8231893
-
Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):3046-50
PMID: 7708772
-
Differential activation of peroxisome proliferator-activated receptors by eicosanoids.
J Biol Chem. 1995 Oct 13;270(41):23975-83
PMID: 7592593
-
Improved dicistronic mRNA expression vectors for efficient selection of transfectants highly expressing foreign genes.
Biotechniques. 1996 Sep;21(3):398-402
PMID: 8879573
-
Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.
Science. 1997 Mar 21;275(5307):1784-7
PMID: 9065401
-
Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.
Science. 1997 Mar 21;275(5307):1787-90
PMID: 9065402
-
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.
Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4312-7
PMID: 9113986
-
Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis.
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):681-6
PMID: 9435252
-
A simplified system for generating recombinant adenoviruses.
Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2509-14
PMID: 9482916
-
Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.
Cancer Res. 1998 Mar 15;58(6):1130-4
PMID: 9515795
-
Identification of c-MYC as a target of the APC pathway.
Science. 1998 Sep 4;281(5382):1509-12
PMID: 9727977
-
Differentiation and reversal of malignant changes in colon cancer through PPARgamma.
Nat Med. 1998 Sep;4(9):1046-52
PMID: 9734398
-
Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice.
Nat Med. 1998 Sep;4(9):1053-7
PMID: 9734399
-
Activators of the nuclear receptor PPARgamma enhance colon polyp formation.
Nat Med. 1998 Sep;4(9):1058-61
PMID: 9734400
-
Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy.
Clin Cancer Res. 1997 Dec;3(12 Pt 2):2696-702
PMID: 10068276
-
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
Nature. 1999 Apr 1;398(6726):422-6
PMID: 10201372
-
Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta.
Genes Dev. 1999 Jun 15;13(12):1561-74
PMID: 10385625
-
14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage.
Nature. 1999 Oct 7;401(6753):616-20
PMID: 10524633
-
PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance.
Mol Cell. 1999 Oct;4(4):597-609
PMID: 10549291
-
Roles of PPARs in health and disease.
Nature. 2000 May 25;405(6785):421-4
PMID: 10839530